Published: 07-12-2022 17:50 | Updated: 09-12-2022 13:13

The Division of Neurogeriatrics receives a large EU grant

Photo of Euro bills.
Photo: Markus Spiske, Unsplash

Linus Jönsson, affiliated researcher at NVS, Division of Neurogeriatrics, receives EUR 11 million in EU funding for his project "PROMINENT - Precision Medicine in Neurodegeneration". Of this grant, EUR 1.8 million go to KI.

Linus Jönsson, Division of Neurogeriatrics, NVS. Photo: Naventus

Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually.

PROMINENT will develop a digital platform for precision medicine that will remove barriers that currently exists for leveraging these technological advancements in the routine care of patients with neurodegenerative disorders and co-morbidities. The platform gives clinicians access to prediction models leveraging multimodal diagnostic data automatically derived from multiple sources (imaging repositories, medical records, mobile devices), helping them choose optimal care pathways and improving diagnostic precision. It will provide personalized, relevant and meaningful information on diagnosis and prognosis in a format understandable by patients and care partners.

The expected impact of the project is to increase diagnostic accuracy and optimized use of existing and new treatment options. It will empower patients and caregivers by engaging them in more personcentric health care decisions, leading to improved adherence and patient experience. Ultimately this is expected to lead to costeffective care, improved health outcomes and quality of life.

(Excerpt from the abstract)